ASSERTIO THERAPEUTICS, INC. Restructuring and Related Cost, Expected Cost Remaining
ASSERTIO THERAPEUTICS, INC. had Restructuring and Related Cost, Expected Cost Remaining of $0 as of 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1 · last filed 2019-03-11
- 2018-12-31: Restructuring and Related Cost, Expected Cost Remaining $0.00.
| Period end | Restructuring and Related Cost, Expected Cost Remaining |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-11 |